Larson, S., Farooq, U., Latif, T., Mensah, F., Hunter, B., Ciurea, S., Koshy, N., Bryan, L., Hu, B., Clark, W., Yasin, H., Kim, Y., Kaufman, G., Merchant, A. (2025). Rondecabtagene autoleucel, an autologous, dual-targeting CD19/CD20 CAR T-cell candidate manufactured from CD62L+ enriched T cells, achieves durable responses in patients with large B-cell lymphoma. Blood. https://doi.org/10.1182/blood-2025-668